Compare TJX Companies Inc (TJX) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TJX Companies Inc vs TransMedics Group Inc — how do they compare? TJX Companies Inc trades at $155 (market cap $172.00B), while TransMedics Group Inc trades at $74.3 (market cap $2.54B). The key difference: TJX Companies Inc is far larger — about 67.7× TransMedics Group Inc's market cap, and TJX Companies Inc pays a 1.23% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| TJX | TMDX | |
|---|---|---|
Market Cap | $172.00B | $2.54B |
Sector | Consumer Cyclical | Technology |
52-Week High | $168.41 | $150.42 |
52-Week Low | $124.53 | $61.99 |
Enterprise Value | $180.60B | $2.94B |
Dividend Yield | 1.23% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About TJX Companies Inc
TJX is a leading off-price retailer of apparel, home fashions, and other merchandise. It sells a variety of branded goods, opportunistically buying inventory from a network of over 21,000 vendors worldwide. TJX targets undercutting conventional retailers' regular prices by 20%-60%, capitalizing on a flexible merchandising network, relatively low-frills stores, and a treasure-hunt shopping experience to drive margins and inventory turnover. TJX derived 79% of fiscal 2022 revenue from the United States, with 11% from Europe (mostly the United Kingdom and Germany), 9% from Canada, and the remainder from Australia. The company operated 4,689 stores at the end of fiscal 2022 under the T.J. Maxx, T.K. Maxx, Marshalls, HomeGoods, Winners, Homesense, Winners, and Sierra banners.
Read more on TJX →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
